Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
American Journal of Respiratory Cell and Molecular Biology|April 10, 2025
Docosahexaenoic Acid and Its Metabolites Protects Against Ozone-induced Pulmonary InflammationMichael J Yaeger, Tyson Ngatikaura, Natali Zecchino, et al.
Vaccine|February 23, 2024
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of ageSanjeev M Bijukchhe, Meeru Gurung, Bhishma Pokhrel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge ModelHazel C Dobinson, Malick M Gibani, Claire Jones, et al.
Health Policy and Planning|December 20, 2020
How to reduce household costs for people with tuberculosis: a longitudinal costing survey in NepalSuman Chandra Gurung, Bhola Rai, Kritika Dixit, et al.
The Lancet. Infectious Diseases|January 27, 2016
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trialAmit Arjyal, Buddha Basnyat, Ho Thi Nhan, et al.
Plos Neglected Tropical Diseases|April 15, 2026
Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA studyJo Walker, Paula Russell, Leanne Kermack, et al.
Plos Neglected Tropical Diseases|October 9, 2025
Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA studyJo Walker, Paula Russell, Leanne Kermack, et al.
High Altitude Medicine & Biology|March 21, 2006
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trialBuddha Basnyat, Jeffrey H Gertsch, Peter S Holck, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesChristopher M Parry, Chau Tran Thuy, Sabina Dongol, et al.
Trials|November 26, 2020
Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trialOlawale Salami, Philip Horgan, Catrin E Moore, et al.
Pageof 38